ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,624Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 123

$750K Total Retail Price of All Prescriptions

Rank: 4 out of 123

1,028 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,028 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 15,619 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
METOPROLOL SUCCINATE 938 847 1 3
SIMVASTATIN 908 805 2 6
LISINOPRIL 815 689 3 2
CLOPIDOGREL 785 702 4 7
AMLODIPINE BESYLATE 771 708 5 5
FUROSEMIDE 732 674 6 4
SOTALOL 546 487 7 24
OMEPRAZOLE 517 484 8 22
PLAVIX 479 442 9 13
WARFARIN SODIUM 410 366 10 12
DIGOXIN 372 341 11 16
METOPROLOL TARTRATE 349 287 12 9
CARVEDILOL 317 288 13 1
LEVOTHYROXINE SODIUM 316 299 14 30
NADOLOL 305 231 10 15 89
ATORVASTATIN CALCIUM 304 257 16 10
POTASSIUM CHLORIDE 298 283 17 14
LOSARTAN POTASSIUM 277 252 18 21
CRESTOR 215 200 19 15
DOXAZOSIN MESYLATE 211 194 20 67
PANTOPRAZOLE SODIUM 209 198 21 37
METFORMIN HCL 205 180 22 56
BYSTOLIC 186 158 23 26
HYDROCHLOROTHIAZIDE 177 158 24 19
ATENOLOL 176 146 25 20
AMIODARONE HCL 174 164 26 17
NEXIUM 142 119 27 63
LANOXIN 140 138 28 80
TAMSULOSIN HCL 140 116 28 81
EFFIENT 138 108 30 41
NITROSTAT 133 114 31 23
ISOSORBIDE MONONITRATE ER 131 110 32 11
ZOLPIDEM TARTRATE 121 115 33 55
AMLODIPINE BESYLATE-BENAZEPRIL 117 99 34 52
VYTORIN 116 99 35 50
PROPAFENONE HCL 106 106 36 34
FLECAINIDE ACETATE 105 81 37 58
BENAZEPRIL HCL 103 98 38 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 97 39 27
RANITIDINE HCL 100 87 39 93
PRAVASTATIN SODIUM 97 67 41 8
LOSARTAN-HYDROCHLOROTHIAZIDE 91 87 42 42
DIOVAN HCT 89 84 43 51
CILOSTAZOL 88 85 44 47
SPIRONOLACTONE 84 64 45 18
LIPITOR 82 80 46 38
ALLOPURINOL 80 73 47 76
DIPYRIDAMOLE 79 73 R 48 143
DIOVAN 75 66 49 25
GABAPENTIN 75 73 49 56
TRIAMTERENE-HCTZ 75 58 49 46
TRICOR 74 56 52 61
LOVASTATIN 72 54 53 49
SYNTHROID 72 72 53 97
NIFEDICAL XL 70 63 55 100
CITALOPRAM HBR 69 67 56 65
DILTIAZEM 24HR CD 69 48 56 43
GLIMEPIRIDE 69 64 56 99
MICARDIS HCT 66 66 59 149
TERAZOSIN HCL 63 63 60 115
GLYBURIDE-METFORMIN HCL 62 52 R 61 153
ZETIA 60 59 62 33
KLOR-CON 10 59 50 63 78
FINASTERIDE 58 58 64 155
ENALAPRIL MALEATE 58 58 64 39
AMITRIPTYLINE HCL 58 49 R 64 101
HYDRALAZINE HCL 57 48 67 28
PRADAXA 57 54 67 32
FENOFIBRATE 56 52 69 44
FAMOTIDINE 56 45 69 70
ALENDRONATE SODIUM 56 56 69 159
RAMIPRIL 53 46 72 29
DONEPEZIL HCL 52 52 73 114
MELOXICAM 51 45 74 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.